These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7534147)

  • 1. Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents.
    Jachez B; Cianfriglia M; Loor F
    Anticancer Drugs; 1994 Dec; 5(6):655-65. PubMed ID: 7534147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents.
    Boesch D; Loor F
    Anticancer Drugs; 1994 Apr; 5(2):229-38. PubMed ID: 7914109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B; Nilsson K; Nygren P; Larsson R
    Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
    Lehne G; De Angelis P; den Boer M; Rugstad HE
    Leukemia; 1999 May; 13(5):768-78. PubMed ID: 10374882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDZ PSC 833 and SDZ 280-446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells.
    Pourtier-Manzanedo A; Didier AD; Muller CD; Loor F
    Anticancer Drugs; 1992 Aug; 3(4):419-25. PubMed ID: 1421439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
    Lehne G; Rugstad HE
    Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topology of MDR1-P-glycoprotein as indicated by epitope mapping of monoclonal antibodies to human MDR cells.
    Cianfriglia M; Poloni F; Signoretti C; Romagnoli G; Tombesi M; Felici F
    Cytotechnology; 1996; 19(3):247-51. PubMed ID: 8862014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells.
    Cianfriglia M; Willingham MC; Tombesi M; Scagliotti GV; Frasca G; Chersi A
    Int J Cancer; 1994 Jan; 56(1):153-60. PubMed ID: 7505264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
    Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
    Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
    Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR; Burgess R; Fisher A; Yin JA
    Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein.
    Lehne G; De Angelis P; Clausen OP; Egeland T; Tsuruo T; Rugstad HE
    Cytometry; 1995 Jul; 20(3):228-37. PubMed ID: 7587708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
    Maki N; Hafkemeyer P; Dey S
    J Biol Chem; 2003 May; 278(20):18132-9. PubMed ID: 12642584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.
    Taylor BJ; Olson DP; Ivy SP
    Leuk Res; 2001 Dec; 25(12):1127-35. PubMed ID: 11684287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
    Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.